Dbv Technologies S.A. (DBVT)Chief Medical Officer sold ~$2.6K

~$2.6K

Approx. value · 534 sh @ $4.86

145K

Holds after · shares reported

Traded

Jan 29, 2026

Filed

Feb 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 17, 2025Insider · 1 personInsiders: 2 sales (~$10.1M)
2. Dec 18, 2025InsiderInsider sold ~$5.41M of DBVT shares in the open market
3. Jan 29, 2026 · this disclosureInsiderOfficer sold ~$2.6K of DBVT shares in the open market

What came next

1. Mar 26, 2026Company filing · Form 8-K · ResultsReported its results
2. Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
3. Apr 30, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 30, 2026 the Board of Directors (the “ Board ”) of DBV Technologies S.A. (the “ Company ”), upon recommendation of the Compensation Committee (the “ Committee ”) of the Board, approved the DBV Technologies 2026 Performance Share Unit Plan (the “ Plan ”), and granted performance share units pursuant to the Plan (“ PSUs ”) to Daniel Tassé, the Company’s Chief Executive Officer (the “ CEO ,” or, alternately,…”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Dbv Technologies S.A.

For Dbv Technologies S.A., OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DBVT page.

Other recent filings by Pharis Mohideen, Chief Medical Officer

• SEC Form 4 at Dbv Technologies S.A. (DBVT)Jul 31, 2026
• SEC Form 4 at Dbv Technologies S.A. (DBVT)Nov 25, 2025
• SEC Form 4 at Dbv Technologies S.A. (DBVT)Nov 25, 2025
• SEC Form 4 at Dbv Technologies S.A. (DBVT)Jul 31, 2025
• SEC Form 4 at Dbv Technologies S.A. (DBVT)May 27, 2025

The full history of Pharis Mohideen, Chief Medical Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Dbv Technologies S.A.

• SEC Form 13F-HRAug 14, 2026
• SEC Form 4Jul 31, 2026
• SEC Form 13F-HRMay 29, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 13, 2026
• SEC Form 4Dec 19, 2025

Everything OQRO holds on this company is on its DBVT page.